BELLEZZA, Guido
 Distribuzione geografica
Continente #
NA - Nord America 4.518
EU - Europa 3.786
AS - Asia 1.151
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
SA - Sud America 5
AF - Africa 4
Totale 9.479
Nazione #
US - Stati Uniti d'America 4.467
IT - Italia 883
IE - Irlanda 822
UA - Ucraina 705
SE - Svezia 419
HK - Hong Kong 392
SG - Singapore 300
CN - Cina 193
FI - Finlandia 188
DE - Germania 174
RU - Federazione Russa 156
VN - Vietnam 156
GB - Regno Unito 107
FR - Francia 82
RO - Romania 82
KR - Corea 61
CA - Canada 46
BE - Belgio 35
CH - Svizzera 23
PL - Polonia 22
TR - Turchia 17
AT - Austria 16
PT - Portogallo 14
NL - Olanda 13
GR - Grecia 11
LB - Libano 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 8
ES - Italia 7
AU - Australia 6
EU - Europa 6
MX - Messico 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BR - Brasile 3
IL - Israele 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
NO - Norvegia 2
TH - Thailandia 2
BO - Bolivia 1
CL - Cile 1
EE - Estonia 1
HU - Ungheria 1
JO - Giordania 1
JP - Giappone 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TW - Taiwan 1
Totale 9.479
Città #
Chandler 1.003
Dublin 821
Hong Kong 392
Jacksonville 386
San Mateo 367
Boardman 329
Perugia 213
Singapore 202
Ann Arbor 189
Medford 184
Princeton 183
Altamura 159
Dong Ket 156
Wilmington 147
Lawrence 120
Andover 107
Ashburn 96
Beijing 82
Bucharest 79
Seoul 61
Saint Petersburg 53
Ottawa 45
Woodbridge 40
Des Moines 39
Helsinki 37
Rome 37
Redmond 36
Brussels 34
Norwalk 34
Shanghai 33
San Paolo di Civitate 30
Los Angeles 24
New York 24
Redwood City 23
Houston 20
Milan 20
Santa Clara 20
Auburn Hills 19
Munich 18
Izmir 17
Philadelphia 17
Kraków 16
Moscow 16
Falls Church 11
Dallas 9
Den Haag 9
Florence 9
West Jordan 8
Palermo 7
Simi Valley 7
Bologna 6
Marinha Grande 6
Nürnberg 6
Edinburgh 5
Fremont 5
Lappeenranta 5
Lausanne 5
Abidjan 4
Arezzo 4
Catania 4
Lisbon 4
Perth 4
Tappahannock 4
Terni 4
Amsterdam 3
Avellino 3
Bratislava 3
Castellarano 3
Chicago 3
Como 3
Frankfurt Am Main 3
Frankfurt am Main 3
Kiev 3
Marano Di Napoli 3
Montalto delle Marche 3
Montesilvano Marina 3
Paris 3
Phoenix 3
Serra 3
Terrassa 3
Trieste 3
Bari 2
Bergamo 2
Brno 2
Castel Bolognese 2
Chieti 2
Costa Mesa 2
Dearborn 2
Faenza 2
Fairfield 2
Genova 2
Kansas City 2
Lanciano 2
London 2
Messina 2
Monmouth Junction 2
Nanjing 2
Naples 2
Nocera Superiore 2
Padova 2
Totale 6.143
Nome #
Angiosarcoma primitivo del surrene 190
Granuloma piogenico: revisione della letteratura e presentazione di un caso 156
Condromatosi sinoviale primitiva dei tessuti molli. 143
Espressione della sialoproteina ossea, dell’osteopontina e dell’osteonectina nel carcinoma prostatico 140
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 140
Primary mucinous carcinoma of the skin 101
Nuovi metodi di rilevazione delle micrometastasi linfonodali. XXIII Congresso Nazionale di Chirurgia Oncologica 100
Significato prognostico dell’espressione immunoistochimica di Insulin like growth facor receptor 1 (IGFR-1) ed epidermal growth factor receptor (EGFR) nei carcinomi non a piccole cellule del polmone (NSCLC). 100
Valutazione anatomo-patologica dell’unità feto-placentare nella morte prenatale. 98
The correlation of protein peroxidation with morphological changes in experimental oestradiol-induced carcinogenesis 97
Aspirato con ago sottile dei noduli tiroidei: striscio convenzionale vs preparato in strato sottile. 97
Prognostic Role of Erbb Family Receptors, Myc and Mitogen-activated Protein Kinase (mapk) In Patients With Early-stage Non Small-cell Lung Cancer 92
p53 overexpression predicts the resistance to chemotherapy in advanced non small cell lung cancer (NSCLC)". 90
Immunohistochemical expression of IMP3 in non small cell lung cancer. 89
Nested Type Bladder Cancer: A Tricky Entity A Report of Two Cases 89
Leiomyoma of the breast: case report and review of the literature. 88
Ruolo dei marcatori biologici negli stadi iniziali dei NSCLC tattati con resezione chirurgica radicale. Congresso Nazionale SICO 85
Ossificazione eterotopica e patologia tiroidea: descrizione di 6 casi e revisione della letteratura 84
P-126 * PROGNOSTIC SIGNIFICANCE OF MYC AND HUMAN TELOMERASE GENE AMPLIFICATION IN SURGICALLY TREATED EARLY STAGE NON-SMALL CELL LUNG CANCER 81
Biological Prognostic Factors for early stage completely resected NSCLC 78
Espressione di EGFR e timidilato sintetasi nel carcinoma rettale: correlazioni anatomo-cliniche e significato prognostico - IV Congresso Nazionale di Anatomia Patologica 78
Appendiceal mucocele. A case report and literature review 78
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer 77
Predictors of resistance to chemotherapy and prognosis in advanced non-small cell lung cancer. 76
Espressione di MKP-1 nei noduli iperplastici, adenomi e carcinomi papillari della tiroide. 76
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non small cell lung cancer (NSCLC) 75
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis 75
Apocrine intraductal carcinomas arising in two fibroadenomas: report of an unusual case. 73
Coexpression of HER-2/neu and p53 in breast cancer identifies a subset with an aggressive biopathological profile. 73
Fine needle aspiration cytology of thyroid nodules: conventional smears vs thin layer technique 72
6th National Conress of Medical Oncology 70
CD10 is frequently expressed in classical seminomas. 70
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free servival in resected non-small-cell lung cancer patients. 69
ATTIVAZIONE IN SITU DELLE METALLOPROTEINASI DA PARTE DEL SISTEMA FIBRINOLITICO COME MECCANISMO PATOGENETICO DELLA ROTTURA DELLA PLACCA ATEROSCLEROTICA. 68
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 66
An additional case of breast tumor resembling the tall cell variant of papillary thyroid carcinoma. 65
Espressione delle citocheratine basali nei carcinomi mammari pT1b: studio clinico patologico. 64
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer 64
Future options for ALK-positive non-small cell lung cancer 64
1° Simposio Nazionale di Citopatologia "Dallo screening alla citologia diagnostica" 63
Confronto tra citologia aspirativa con ago sottile e parametri eco-color-doppler nei noduli tiroidei 63
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. 62
Dyskerin and TERC expression may condition survival in lung cancer patients 61
HER family receptors expression in squamous cell carcinoma of the tongue: study of the possible prognostic and biologic significance 59
Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERα 59
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 59
Tumori a cellule granulari (TCG): nuovi marcatori imunoistochimici. 58
Comparison between fine needle aspiration cytology and ultrasound features in thyroid nodules: an US score to select thyroid nodules requiring FNA. 58
Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hibridization. 58
Breast cancer in young women: clinicopathological features and biological specificity. 58
Glyoxalase 2 drives tumorigenesis in human prostate cells in a mechanism involving androgen receptor and p53-p21 axis. 58
SIGNIFICATO PROGNOSTICO DI ALCUNI PARAMETRI BIOPATOLOGICI IN 99 CASI DI CARCINOMA DEL POLMONE NON-MICROCITOMA STADIO I-II. Atti congresso congiunto: Società italiana Anatomia Patologica e Citologia Diagnostica (SIAPEC) e International Academy of Pathology (IAP). Pathologica Vol 91 57
Carcinoma della mammella pT1a: studio clinico-patologico 57
Tumore stromale gastrointestinale (GIST) in diverticolo di Meckel: descrizione di due casi 57
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors. 57
Mitotic index matter: how to improve the assessment of mitosis in order to better classify G2 breast cancer and luminal A category 57
Modificazioni del profilo biopatologico del carcinoma della mammella: un ulteriore effetto dello screening mammografico? 56
Carcinomi mammari "triple negative": studio dei fattori prognostici e predittivi. 56
Endometriosis-associated skeletal muscle regeneration: a hitherto undescribed entity and a potential diagnostic pitfall. 56
Carcinomi mammari “triple negative”: studio dei fattori prognostici e predittivi 56
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC). 56
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition 56
Could thymomectomy be a reasonable option for non-myasthenic thymoma patients? 56
Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients. 56
Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib 56
Classification Model to Estimate MIB-1 (Ki 67) Proliferation Index in NSCLC Patients Evaluated With 18F-FDG-PET/CT 56
Biological prognostic factors for early stage completely resected non-small cell lung cancer. 56
Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro. 55
Espressione delle proteine osteogenetiche nel carcinoma prostatico: correlazioni anatomo-cliniche e significato prognostico 55
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: An experimental study 55
Detection of HER-/neu (c-erbB-2). Overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization. 53
Carcinoma della mammella pT1a: studio clinico-patologico 53
Espressione dei recettori HER nei carcinomi non a piccole cellule del polmone 53
Targeting the KRAS variant for treatment of non-small cell lung cancer: Potential therapeutic applications 53
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor 53
IMP3 protein expression in triple negative breast carcinoma. 52
The clinical relevance of Bcl-2, Rb, p53 overexpression in advanced non small cell lung cancer. 51
Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. 51
Pleurodesis with Thulium Cyber Laser versus talc poudrage: a comparative experimental study 51
Attivazione in situ delle metalloproteinasi da parte del sistema fibrinolitico come meccanismo patogenetico della rottura della placca aterosclerotica. 50
Primary signet-ring cell carcinoma of the urinary tract 50
Lymphangiogenesis in cutaneous melanoma:prognostic significance and correlation with sentinel lymph node status. 50
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 50
Observational analysis on inflammatory reaction to talc pleurodesis: Small and large animal model series review 49
Low dentin matrix protein 1 expression correlates with skeletal metastases development and enhances cell migratory capacity in vitro. 48
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors 48
How might treatment of ALK-positive non-small cell lung cancer change in the near future? 48
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib 48
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients 48
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer 48
Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer 48
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 48
Ercc1 Mrna Expression and Kras Mutation Status In Egfr Wild Type (wt) Advanced Non-small Cell Lung Cancer (nsclc) Patients 47
Immunohistochemical analisis of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in papillary thyroid carcinoma (PYC): a marker of lymph node metastasis. 47
Systems biology in personalized medicine in oncology: A case study in non-small cell lung cancer 47
Osimertinib 47
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy 47
Biopathologic Profile of breast cancer in core biopsy: is it always a valid method? 46
Carcinomi mammari “tripli negativi”: significato biologico e prognostico dell’espressione di ERCC1. 45
Espressione immunoistochimica di TTF-1 e Galectina-3 su tissue microarray in 145 casi di carcinoma non a piccole cellule del polmone (NSCLC): correlazion anatomo-clinica e possibile significato prognostico. 45
Totale 6.747
Categoria #
all - tutte 40.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.650


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020664 0 0 0 15 101 20 111 39 146 110 35 87
2020/20211.554 14 103 68 122 447 101 136 21 165 53 132 192
2021/20221.583 37 287 30 91 30 22 20 463 48 91 182 282
2022/20232.968 219 540 37 275 257 291 12 136 1.066 9 101 25
2023/20241.229 82 117 56 15 10 28 317 48 140 42 181 193
2024/2025535 74 303 158 0 0 0 0 0 0 0 0 0
Totale 9.974